Characteristics of patients with DVT
| Characteristics . | Total (n = 70) . |
|---|---|
| Age, mean ± SD y | |
| Current (range, y) | 50.1 ± 14.4 |
| (21-79) | |
| At first VTE episode, | 45.5 ± 14.2 |
| Other characteristics, n (%) | |
| Gender (female) | 35 (50) |
| VTE | |
| Recurrent | 18 (26) |
| Spontaneous | 43 (61.4) |
| Recent surgery | 4 (5.7) |
| Recent trauma | 8 (16) |
| Malignant neoplasm | |
| Active | 3 (4.3) |
| Previous | 2 (2.8) |
| Leg paresis | 1 (1.4) |
| Prolonged travel | 4 (5.7) |
| Oral contraceptive | 4 (5.7) |
| Tamoxifen use | 1 (1.4) |
| Other diseases | |
| Puerperium | 1 (1.4) |
| Inflammatory bowel disease | 2 (2.9) |
| Bechet disease | 1 (1.4) |
| Characteristics . | Total (n = 70) . |
|---|---|
| Age, mean ± SD y | |
| Current (range, y) | 50.1 ± 14.4 |
| (21-79) | |
| At first VTE episode, | 45.5 ± 14.2 |
| Other characteristics, n (%) | |
| Gender (female) | 35 (50) |
| VTE | |
| Recurrent | 18 (26) |
| Spontaneous | 43 (61.4) |
| Recent surgery | 4 (5.7) |
| Recent trauma | 8 (16) |
| Malignant neoplasm | |
| Active | 3 (4.3) |
| Previous | 2 (2.8) |
| Leg paresis | 1 (1.4) |
| Prolonged travel | 4 (5.7) |
| Oral contraceptive | 4 (5.7) |
| Tamoxifen use | 1 (1.4) |
| Other diseases | |
| Puerperium | 1 (1.4) |
| Inflammatory bowel disease | 2 (2.9) |
| Bechet disease | 1 (1.4) |